ArticleACR open rheumatology2022

Cardiovascular and Venous Thromboembolic Risk With Janus Kinase Inhibitors in Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis of Randomized Trials.

Muhammad Haisum Maqsood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.